Philip Toleikis
Chief Tech/Sci/R&D Officer bij SERNOVA CORP.
Vermogen: 2 M $ op 31-03-2024
Profiel
Philip M.
Toleikis is currently the Director & Chief Technology Officer at Sernova Corp.
since 2023.
He is also a Member of the Medway Working Group.
Previously, he worked as the VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. from 1999 to 2006.
Dr. Toleikis holds a doctorate degree from the University of British Columbia, a graduate degree from the University of Michigan, and an undergraduate degree from the University of Vermont.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SERNOVA CORP.
1.74% | 25-04-2023 | 5 273 598 ( 1.74% ) | 2 M $ | 31-03-2024 |
Actieve functies van Philip Toleikis
| Bedrijven | Functie | Begin |
|---|---|---|
| SERNOVA CORP. | Chief Tech/Sci/R&D Officer | 05-09-2023 |
| Medway Working Group | Corporate Officer/Principal | - |
Eerdere bekende functies van Philip Toleikis
| Bedrijven | Functie | Einde |
|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01-01-2006 |
Opleiding van Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
